Oral Oncology
Volume 46, Issue 7 , Pages 536-542, July 2010

Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma

  • Ahmad Waseem

      Affiliations

    • Centre for Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Turner Street, London E1 2AD, England, United Kingdom
  • ,
  • Muhammad Ali

      Affiliations

    • Centre for Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Turner Street, London E1 2AD, England, United Kingdom
  • ,
  • Edward W. Odell

      Affiliations

    • Head and Neck Oncology Group, King’s College London Dental Institute, Guy’s Hospital Campus, London SE1 9RT, United Kingdom
  • ,
  • Farida Fortune

      Affiliations

    • Centre for Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Turner Street, London E1 2AD, England, United Kingdom
  • ,
  • Muy-Teck Teh

      Affiliations

    • Centre for Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Turner Street, London E1 2AD, England, United Kingdom
    • Corresponding Author InformationCorresponding author. Address: Centre for Clinical & Diagnostic Oral Sciences, Barts & the London School of Medicine & Dentistry, 4, Newark Street, London E1 2AT, United Kingdom. Tel.: +44 (0) 20 7882 7140; fax: +44 (0) 20 7882 7137.

Received 18 February 2010; received in revised form 18 March 2010; accepted 18 March 2010. published online 20 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1368-8375(10)00118-1

doi:10.1016/j.oraloncology.2010.03.022

Oral Oncology
Volume 46, Issue 7 , Pages 536-542, July 2010